A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis

Autor: Thakur, C.P., Kanyok, T.P., Pandey, A.K., Sinha, G.P., Zaniewski, A.E., Houlihan, H.H., Olliaro, P.
Zdroj: In Transactions of the Royal Society of Tropical Medicine and Hygiene 2000 94(4):429-431
Databáze: ScienceDirect